|
Market Cap (21-Mar) $7,470,680 (0th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 172,500 |
Shortsold (8-Aug) 11,000 (0.01%) (605th) |
|
52w High $0.050 |
52w Low $0.020 |
P/E - |
EPS -0.01 |
IRX released this announcement to the ASX on 30 March 2023, 15:37. The announcement is not marked as price sensitive, and is 24 page(s) in length and 559.7kb in size.
You can view all announcements from IRX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IRX was 0.002% short sold according to ASIC data. It was ranked the 632nd most shorted stock on the ASX. It is now ranked as the 605th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (08 August 2023).
| Other Recent Announcements from IRX | |
|---|---|
| First Cohort Complete for Phase 1, Pain Indication IRX211 | 14 June 2023, 9:56 |
| First Patient Dosed for Phase 1, Pain Indication IRX211 | 7 June 2023, 9:54 |
| Constitution | 6 June 2023, 17:05 |
| Appendix 4G & Corporate Governance Statement | 30 March 2023, 15:37 |
| Ethics Approval for Phase 1 CRPS | 21 March 2023, 9:55 |
| Change in substantial holding | 2 March 2023, 15:04 |
| Section 708A Notice | 1 March 2023, 16:14 |
You must be logged in to post a reply.
